What is the difference between ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE and ALBUTEROL?

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE and ALBUTEROL are both Beta-2 Agonist Bronchodilators, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE the same as Albuterol?

No. ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE (ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE) and Albuterol (ALBUTEROL) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Can I switch from ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE to ALBUTEROL?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs ALBUTEROL

Compare ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE (Beta-2 Agonist Bronchodilator) and ALBUTEROL (Albuterol) — clinical data, side effects, and patient experiences.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

· Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action DUAKLIR PRESSAIR DUAKLIR PRESSAIR contains two bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formo...

Approved for

5.4 )] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic

and formoterol fumarate

5.4 )

Respiratory (inhalation)Tablet

ALBUTEROL

Albuterol, ProAir, Ventolin · Beta-2 Agonist Bronchodilator

How it works

Other agent

Approved for

INDICATIONS AND USAGE Albuterol tablets

USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

OralTablet

Quick Comparison

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATEALBUTEROL

Drug Class

Beta-2 Agonist Bronchodilator

Route

Respiratory (inhalation)

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

Shortness of Breath

>10%

Cough

1-10%

Drug Not Working

0.1-1%

General Unwellness

0.1-1%

ALBUTEROL

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Diarrhea

0.1-1%

General Unwellness

0.1-1%

FDA Warnings

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

5 WARNINGS AND PRECAUTIONS • Asthma-related death: Long-acting beta 2 -adrenergic agonists as monotherapy (without an inhaled corticosteroid) for asthma increase the risk of serious asthma-related events
2 ) • Do not use in combination with an additional medicine containing a LABA because of risk of overdose
1 Serious Asthma-Related Events-Hospitalizations, Intubations, Death • The safety and efficacy of DUAKLIR PRESSAIR in patients with asthma have not been established
• Use of LABA as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death

ALBUTEROL

WARNINGS Paradoxical Bronchospasm Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening

Clinical Trial Data

No head-to-head clinical studies found for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs ALBUTEROL.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs ALBUTEROL: What You Should Know

Key Differences

Both ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE and ALBUTEROL belong to the Beta-2 Agonist Bronchodilator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE is administered via Respiratory (inhalation), whereas ALBUTEROL uses Oral. Route of administration can affect onset of action and patient adherence.

Safety Considerations

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE carries 4 FDA warnings. ALBUTEROL carries 1 FDA warning. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ALBUTEROL vs FORMOTEROL FUMARATE→ALBUTEROL vs LEVALBUTEROL HYDROCHLORIDE→ALBUTEROL vs FORMOTEROL FUMARATE DIHYDRATE→ALBUTEROL vs TIOTROPIUM BROMIDE AND OLODATEROL→ALBUTEROL vs FLUTICASONE PROPIONATE AND SALMETEROL→ALBUTEROL vs ALBUTEROL SULFATE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
ALBUTEROL: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs ALBUTEROL

Compare ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE (Beta-2 Agonist Bronchodilator) and ALBUTEROL (Albuterol) — clinical data, side effects, and patient experiences.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

· Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action DUAKLIR PRESSAIR DUAKLIR PRESSAIR contains two bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formo...

Approved for

5.4 )] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic

and formoterol fumarate

5.4 )

Respiratory (inhalation)Tablet

ALBUTEROL

Albuterol, ProAir, Ventolin · Beta-2 Agonist Bronchodilator

How it works

Other agent

Approved for

INDICATIONS AND USAGE Albuterol tablets

USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

OralTablet

Quick Comparison

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATEALBUTEROL

Drug Class

Beta-2 Agonist Bronchodilator

Route

Respiratory (inhalation)

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

Shortness of Breath

>10%

Cough

1-10%

Drug Not Working

0.1-1%

General Unwellness

0.1-1%

ALBUTEROL

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Diarrhea

0.1-1%

General Unwellness

0.1-1%

FDA Warnings

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

5 WARNINGS AND PRECAUTIONS • Asthma-related death: Long-acting beta 2 -adrenergic agonists as monotherapy (without an inhaled corticosteroid) for asthma increase the risk of serious asthma-related events
2 ) • Do not use in combination with an additional medicine containing a LABA because of risk of overdose
1 Serious Asthma-Related Events-Hospitalizations, Intubations, Death • The safety and efficacy of DUAKLIR PRESSAIR in patients with asthma have not been established
• Use of LABA as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death

ALBUTEROL

WARNINGS Paradoxical Bronchospasm Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening

Clinical Trial Data

No head-to-head clinical studies found for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs ALBUTEROL.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs ALBUTEROL: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
ALBUTEROL: DailyMed label · FAERS adverse events · ClinicalTrials.gov